Yes, the product differences are substantial, and I'm always amazed at people who get the various products so wrong, like saying Recell & NovoSorb compete.
Fully agree with this part... "Only those with high averages will struggle unless they trade to bring their averages down" Some trading, buying dips, selling highs, yet keeping profit as shares has allowed me a nice healthy holding (for me) at a now even lower average.
With expansion of existing product & expanded approvals plus new product use trials underway I see a lot to like. I acknowledge a company misstep or two but am happy enough that the positives outweigh any negatives, imho.
AVH Price at posting:
$5.35 Sentiment: Hold Disclosure: Held
(20min delay)